Regression of Kayser-Fleischer rings during oral zinc therapy: Correlation with systemic manifestations of Wilson's disease

Cornea

Volumn 15, Issue 6, 1996, Pages 582-588

  Esmaeli, Bita ^a   Burnstine, Michael A ^a   Martonyi, Csaba L ^a   Sugar, Alan ^a,b   Johnson, Virginia ^a   Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Kayser Fleischer rings; Magnetic resonance imaging; Neuropsychiatry; Slit lamp photography; Tetrathiomolybdate; Wilson's disease; Zinc

Indexed keywords

CERULOPLASMIN; COPPER; MOLYBDENUM; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; ZINC; ZINC ACETATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER METABOLISM; CORNEA DISEASE; DESCEMET MEMBRANE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SINGLE BLIND PROCEDURE; SLIT LAMP; SPEECH; URINE LEVEL; WILSON DISEASE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BRAIN DISEASES; COPPER; CORNEA; CORNEAL DISEASES; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MOLYBDENUM; PROSPECTIVE STUDIES; ZINC;

EID: 0029957173     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bull PC, Cox DW. Wilson disease and Menkes disease: new handles on heavy metal transport. Trends Genet 1994;10: 246-52.
2. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992;71:139-64.
3. Kayser B. Ubereinemfullven Augelborener Grunlicher Verforbung der Cornea. Klin Monatsbl Augenheilkd 1902;40: 22-5.
4. Weinberg LM, Brasitus TA, Lefkowitch JH. Fluctuating Kayser-Fleischer-like rings in a jaundiced patient. Arch Intern Med 1981;141:246-7.
5. Kaplinsky C, Sternlieb I, Javitt N, et al. Familial cholestatic cirrhosis associated with Kayser-Fleischer rings. Pediatrics 1980;65:782-8.
6. Fleming CR, Dickson ER, Wahner HW, et al. Pigmented corneal rings in non-Wilsonian liver disease. Ann Intern Med 1977;86:285-8.
7. Frommer D, Morris J, Sherlock S, et al. Kayser-Fleischer-like rings in patients without Wilson's disease. Gastroenterology 1977;72:1331-5.
8. Rimola A, Bruguera M, Rodes J. Kayser-Fleischer-like ring in cryptogenic cirrhosis. Arch Intern Med 1978;138:1857-8.
9. Willeit J, Kiechl SG. Wilson's disease with neurological impairment but no Kayser-Fleischer rings. Lancet 1991;337: 1426.
10. Tauber J, Steinert RF. Pseudo-Kayser-Fleischer ring of the cornea associated with non-Wilsonian liver disease, a case report and literature review. Cornea 1993;12:74-7.
11. Brewer GJ, Dick RD, Johnson V, et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate: initial therapy in 17 neurologically affected patients. Arch Neurol 1994;51:545-54.
12. Brewer GJ, Hill GM, Prasad AS, et al. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983;99:314-20.
13. Walshe JM. Penicillamine; a new oral therapy for Wilson's disease. Am J Med 1956;21:487-95.
14. Brewer GJ, Terry CA, Aisen AM, et al. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987;44:490-3.
15. Brewer GJ, Dick RD, Yuzbasiyan-Gurkin V, et al. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol 1991;48:42-7.
16. Hill GM, Brewer GJ, Parsad AS, et al. Treatment of Wilson's disease with zinc I. Oral zinc therapy regimens. Hepatology 1987;7:522-8.
17. Hoogenraad TU, Koevoet R, de Ruyter Korver EGWM. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979;18: 205-11.
18. Young AB, Shoulson I, Penney JB, et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986;36:244-9.
19. Mitchell AM, Heller GL. Changes in Kayser-Fleischer ring during treatment of hepatolenticular degeneration. Arch Ophthalmol 1968;80:622-5.
20. Sussman W, Scheinberg IH. Disappearance of Kayser-Fleischer rings: effects of penicillamine. Arch Ophthalmol 1969;82:738-41.
21. Lobner A, Lobner J, Bachman H, et al. The Kayser-Fleischer ring during long-term treatment in Wilson's disease (hepatolenticular degeneration): a follow-up study. Graefes Arch Clin Exp Ophthalmol 1986;224:152-5.
22. Song HS, Ku WC, Chen CL. Disappearance of Kayser-Fleischer rings following liver transplantation. Transplant Proc 1992;24:1483-5.
23. Schoenberger M, Ellis PP. Disappearance of Kayser-Fleischer rings after liver transplantation. Arch Ophthalmol 1979;97:1914-5.
24. Yuzbasiyan-Gurkan V, Johnson V, Brewer GJ. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. J Lab Clin Med 1991;118:458-65.
25. Schilsky ML. Identification of the Wilson's disease gene: clues for disease pathogenesis and the potential for molecular diagnosis. Hepatology 1994;20:529-35.
26. Schwab SG, Scherer J, Wildenauer DB. Presymptomatic testing in families with Wilson's disease. Lancet 1994;343:1637-8.